2020
DOI: 10.1155/2020/4260204
|View full text |Cite
|
Sign up to set email alerts
|

Exposure to Air Pollution Exacerbates Inflammation in Rats with Preexisting COPD

Abstract: Particulate matter with an aerodynamic diameter equal or less than 2.5 micrometers (PM2.5) is associated with the development of chronic obstructive pulmonary disease (COPD). The mechanisms by which PM2.5 accelerates disease progression in COPD are poorly understood. In this study, we aimed to investigate the effect of PM2.5 on lung injury in rats with hallmark features of COPD. Cardinal features of human COPD were induced in a rat model by repeated cigarette smoke inhalation and bacterial infection for 8 week… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
38
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 38 publications
(40 citation statements)
references
References 47 publications
2
38
0
Order By: Relevance
“…The most common air pollutants comprise polycyclic aromatic hydrocarbons (PAHs), volatile organic compounds (VOCs, e.g., benzene), particulate matter (PM, most commonly PM2.5 and PM10), gaseous pollutants, (carbon-monoxide, nitric oxides, sulphur oxide, ozone, heavy metals) and indoor pollutants, as solid fuels consumption 8 . Although the molecular mechanisms relating air pollutions to skin diseases are not yet fully understood, several in vivo studies have highlighted the occurrence and prominence of the inflammatory state as a common factor of these conditions 9 . Particularly, the activation of a multiprotein complex called inflammasome, has been hypothesized to trigger the inflammatory responses by promoting the maturation of proinflammatory cytokines 10 .…”
Section: Introductionmentioning
confidence: 99%
“…The most common air pollutants comprise polycyclic aromatic hydrocarbons (PAHs), volatile organic compounds (VOCs, e.g., benzene), particulate matter (PM, most commonly PM2.5 and PM10), gaseous pollutants, (carbon-monoxide, nitric oxides, sulphur oxide, ozone, heavy metals) and indoor pollutants, as solid fuels consumption 8 . Although the molecular mechanisms relating air pollutions to skin diseases are not yet fully understood, several in vivo studies have highlighted the occurrence and prominence of the inflammatory state as a common factor of these conditions 9 . Particularly, the activation of a multiprotein complex called inflammasome, has been hypothesized to trigger the inflammatory responses by promoting the maturation of proinflammatory cytokines 10 .…”
Section: Introductionmentioning
confidence: 99%
“…PM contains volatile mixtures of numerous heavy metals, organic compounds, and carcinogens that interact with in vivo cellular mechanisms and induce vascular damage, including endothelium inflammation, development of atherosclerosis, lipid peroxidation, alterations in cytokines and acute phase protein levels (such as CRP), and procoagulant responses [ 41 , 42 ]. The mechanisms by which PM accelerates disease progression in COPD involve changes in the prooxidant-antioxidant balance [ 43 ]. Air PM increases the levels of reactive oxygen species (ROS), disrupts cell homeostasis, or activates the redox-sensitive signaling pathway to activate inflammatory cells, pro-inflammatory gene expression, and cytokine production [ 44 ].…”
Section: Discussionmentioning
confidence: 99%
“…Repeated PM 2.5 also resulted in decreased pulmonary function and emphysema, even at a lower level [31]. PM 2.5 dose-dependently upregulates the expression of matrix metalloproteinase (MMP-9), MMP-12, fibronectin, collagen, and transforming growth factor (TGF)-β1, in which the increased protease activity is highly related to airway remodeling and development of emphysema in COPD [32]. Of note, PM 2.5 exposure could significantly worsen cigarette smoking (CS)-induced changes in COPD, suggesting that PM 2.5 and CS may synergistically promote the occurrence and the development of COPD.…”
Section: Copdmentioning
confidence: 99%